Policies, Procedures, Guidelines and Protocols

Title Policies, Procedures, Guidelines and Protocols Trust Ref No 969-31643 Local Ref (optional) Main points the document covers Who is the document aimed at? Author Approved by (Committee/Director) Approval Date 18/4/16 Initial Equality Impact Screening Full Equality Impact Assessment Lead Director Category Sub Category Document Details Guidelines for Prevention and Management Guidelines for Prevention and Management V 3 Guidance on preventing and managing pressure ulceration. The guidelines will support the delivery of safe and effective care. All healthcare professionals in contact with patients Joy Tickle Tissue Viability Specialist Approval process Clinical Policies Group No No Director of Nursing and Quality Clinical Review date 18/4/19 Who the policy will be distributed to Method Required by CQC Required by NHSLA Other No Date Amendment Policies relevant to all services Distribution Directors, Divisional Managers, Service Leads for dissemination to relevant staff within their areas Publishing to the Trust Website, team meetings/briefings Document Links Amendments History 1 Additional guidance incorporated covering the wider topic of pressure ulcer prevention and management including revised patient leaflet. 2 3 4 5

Contents 1. Introduction 2 2. Purpose 2 2.1 Accountability 2 3. Definitions 2 3.1 A 2 3.2 Pressure 3 3.3 Shearing 3 3.4 Glossary 3 4. Duties 3 4.1 The Board of Directors 3 4.2 The Chief Executive 3 4.3 The Director of Nursing 3 4.4 Clinical Service manager and Professional Leads 4 4.5 Tissue Viability Service 4 4.6 All Staff 5 5. Prevention and Management Risk Assessment: Goals 5 5.1 Identifying at Risk Individuals 5 5.2 Risk Assessment 5 5.3 Waterlow Risk Assessment and Skin Assessment 5 5.4 Waterlow 6 5.5 Waterlow Assessment Tool 6 5.6 Preventative Care Plan 6 5.7 SSKIN Assessment 6 5.7.1 Patient Assessment 6 5.7.2 Nutritional Assessment and Management 6 5.8 Pain Assessment 7 5.9 Moving and Handling Techniques 7 5.10 Repositioning 7 5.11 Transportation 7 5.12 Assessment 7 5.13 Ungradable s 8 5.14 Wound Assessment and Management 8 5.15 Reporting of ation 8 5.16 Action against Advice 8 6. Consultation 8 7. Dissemination and Implementation 9 8. Monitoring Compliance 9 9. References 9 10. Associated Documents 10 11. Appendices 10 Guidelines for Prevention and Management 969-31643 1 April 2016

1 Introduction Shropshire Community Health NHS Trust (SCHT) has a responsibility to make every effort to prevent patients developing pressure ulcers and associated conditions whilst in their care. In addition, the Trust has the responsibility to ensure that there are systemic measures in place to prevent the development of pressure ulcers and associated conditions and to assess and manage them if they should occur. The implications for patients who develop pressure ulcers are devastating in terms of the impact upon their health and social well-being. The cost to the Trust can be significant, in terms of treatment pressure ulcers cost the NHS over 3 million pounds a year with extended hospital stays and treatment. (NHS Midlands and East 2012). 2 Purpose It is the overall purpose of this guideline to reduce the occurrence of pressure ulcers, but should they occur then they should be treated using the most up to date evidence based practice and treatment methods. This guideline aims to provide health professionals across Shropshire Community Health Economy with knowledge to inform and support their actions and decision-making ensuring they can provide the most effective preventative and/or treatment strategy. This guideline is intended as a brief overview and should be read in conjunction with more detailed guidance from (NPUAP, EPUAP, 2014) and (NICE, 2014). 2.1 All healthcare professionals are accountable for their clinical practice. Managers are accountable for ensuring that they are aware of the extent of pressure ulcers within their area and for providing opportunity for appropriate support, education and training for staff. This policy recognises the need for a multidisciplinary approach and the provision of holistic care, which will lead to a reduction of the incidence of pressure ulcers within the county and more effective management of patients with pressure damage, ensuring safe and appropriate use of pressure relieving equipment. 3 Definitions 3.1 A pressure ulcer is a localized injury to the skin and/or underlying tissue usually over a bony prominence, as a result of pressure, or pressure in combination with shear (National Advisory Panel (NPUAP), European Advisory Panel (EUPAP), 2014). Most pressure ulcers are preventable if: the circumstances likely to result in an ulcer and those at risk are identified early, if appropriate preventative measures are implemented without delay. However, it is recognised that with recent improvements in reporting and investigation there are increasing incidence of pressure ulcers that are considered unavoidable (EPUAP 2014). Guidelines for Prevention and Management 969-31643 2 April 2016

3.2 Pressure: Pressure occurs when soft tissue over a bony prominence is compressed between a hard surface and the bone causing pressure greater than the capillary pressure, resulting in localised ischemia. 3.3 Shearing: Shearing forces may occur when a patient slides down the bed. This action produces the destruction of the micro circulation by thrombosis of the vessels, particularly if the heels are dragged on the bed whilst being manoeuvred up the bed (Waterlow 2009). In the elderly, shearing can also contribute to epidermis and dermis separation, usually seen as blistering. 3.4 Glossary: DTI EPUAP NPUAP RCA S/DTI SCHT SEO SI SSKIN TVS Deep Tissue Injury European Advisory Panel National Advisory Panel Root Cause Analysis Serious Deep Tissue Injury Shropshire Community Health Trust Specialist Equpiment Order Form Serious Incident Skin, Surface, Keep Moving, Incontinence, Nutrition Tissue Viability Service 4 Duties 4.1 The Board of Directors are responsible for determining the governance arrangements of the Trust including effective risk management processes. It is responsible for ensuring that the necessary clinical policies, procedures and guidelines are in place to safeguard patients and reduce risk. In addition they will require assurance that clinical policies, procedures and guidelines are being implemented and monitored for effectiveness and compliance. 4.2 The Chief Executive has overall responsibility for patient safety and ensuring that there are effective risk management processes within the Trust which meet all statutory requirements and adhere to guidance issued by the Department of Health. The CEO holds each line manager accountable for meeting objectives and to work together towards meeting the objectives approved by the Board. 4.3 The Director of Nursing is the Executive with delegated responsibility for implementation of Governance arrangements within the Trust. The Director of Nursing and the Medical Director are responsible for overseeing the implementation of this document. Guidelines for Prevention and Management 969-31643 3 April 2016

4.4 Clinical Service Managers and Professional Leads will, for their areas of responsibility, so far as is reasonably practical, ensure that this document is implemented by ensuring that: This document is made available to all staff within their department, and that their staff comply. There is adequate provision of suitable staffing levels, working conditions and environments. Each team will have a registered nurse to act as a link nurse/champion for tissue viability to disseminate updates in care and be a link for their area to/from the Tissue Viability Service (TVS). That their staff are properly informed and trained by ensuring that staff are released for training in undertaking skin assessment and risk assessment and complete the on line training package. They lead the root cause analysis (RCA investigations of any pressure ulcers reported as a Serious Incident in their area and report the outcome of these at the appropriate forums). They complete the investigation within 10 working days to comply with timeframes of reporting. Representation from their areas of responsibility will be identified when an investigation of a SI, using the RCA technique, is being held and presented at the appropriate forums. Action plans and risk reduction measures resulting from the investigation of incidents and serious incidents are developed and implemented to prevent reoccurrence of SIs and there is feedback to their teams of the actions taken in response to investigations. Action plans are monitored until all actions are completed and that the Patient Safety Manager and the Tissue Viability Service are kept informed of progress being made to ensure that Trust s Risk Management System, the Strategic Executive Information System (STEIS) and the Serious Incident reporting system (SORD) system for the Commissioners are completed in a timely manner. 4.5 Tissue Viability Service Are responsible so far as is reasonably practical for: Ensuring that this document reflects National and Commissioner s Guidance, and is disseminated throughout the Trust. Advising on the equipment used in the prevention and treatment of pressure ulcers ensuring it is appropriate and meets the needs of the patient. Overseeing the RCA investigations of pressure ulcers reported as a SI to identify trends and report the outcome of these at the appropriate forums. Maintaining the tissue viability database and provide and present reports as required. Verifying all reported pressure ulcers, SI Grade 3 and 4 pressure ulcers, and complete tissue viability section of Datix. Attend RCA challenge meetings to discuss all Grade 3 and 4 pressure ulcer incidents and jointly decide with the groups whether they are avoidable or unavoidable to health and what the level of harm to the trust will be. Notifying the Professional leads via Datix to complete RCA on all verified Grade 3 and 4 pressure ulcers SI. Monitor the Suspected Deep Tissue Injury (S/DTI) and make a decision and report on Datix re its status after two weeks or earlier (i.e. if an open ulcer Grade 3 or 4 or if still an S/TDI then it remains as an S/TDI). Monitor alongside the managers and the governance team the level of harm for each pressure ulcer incident on Datix. Guidelines for Prevention and Management 969-31643 4 April 2016

4.6 All Staff All staff have a responsibility to ensure that they develop and maintain their knowledge and skills to undertake the duties and responsibilities for their post. Healthcare professionals are responsible for ensuring that their practice and that of untrained staff they supervise comply with this document and that they receive appropriate training and support. All staff are responsible for reporting all pressure ulcers Grade 2 and above as a serious incident (SI) within 24hrs of discovery on the electronic incident reporting system: DATIX and decide the level of harm to the trust, and that the Incident Management Policy including the Management of Serious Incidents is followed. Duty of Candour: The regulatory Duty of Candour came into force in November 2014 as part of the Health and Social Care Regulations. This requires a verbal and written notification of the harm and circumstances where a patient suffers moderate, severe harm or death as a result of the care delivered. These notifications should be given to the patient or their representative where appropriate. The notification must include an apology. Moderate harm is defined as harm requiring a moderate increase in treatment. All pressure ulcers (Grade 2 and above) will require additional treatment, so the Duty of Candour will apply if the care delivered contributed to the development of the ulcer. In many instances an ulcer may develop, and it is not clear if this was due to the care, or other circumstances. In this instance the verbal notification should be given, and a decision made relating to the written notification once the circumstances have been investigated. It is a requirement that compliance with the duty should be recorded. This record should be kept using the incident form. Further details can be found: http://www.shropscommunityhealth.nhs.uk/rte.asp?id=10653&task=view&itemid=103 5 Prevention and Management Risk Assessment: Goals 5.1 To identify at risk individuals prevention and the specific factors placing them at risk. The EPUAP believes that there a number of issues associated with risk assessment tools. Risk assessment should be used as an adjunct to clinical judgement and not as a tool in isolation from other clinical features. 5.2 Risk Assessment: There should be clarification of a full risk assessment in patients to include general medical condition, skin assessment, mobility, moistness, incontinence, nutrition and pain. All strategies related to pressure damage should always be based on the best available evidence. Assessment of risk should be more than just the use of an appropriate risk assessment tool and should not lead to a prospective and inflexible approach to patient care. 5.3 All patients on admission to a caseload must have a Waterlow risk assessment (see appendix 1) and a full body skin assessment (see appendix 2) at their first visit or within 6 hours of admission to a community hospital and any tissue damage must be documented in the skin assessment section of the nursing care plan documentation. Whilst risk assessment should be performed immediately on entry into an episode of care this assessment may take time to fully complete if information is not readily available. Assessment should also be on-going and frequency of re-assessment should be dependent Guidelines for Prevention and Management 969-31643 5 April 2016

on change in the patient s condition within the environment. It is recommended to use a risk assessment tool as an aid of memoir, (NICE 2014). 5.4 The Waterlow pressure ulcer risk assessment scoring system has been shown to be the most frequently used system used in the UK. It must be made very clear that like all simplistic scoring systems it cannot scientifically predict with 100% accuracy the chance of a patient developing a pressure ulcer. What it can do, is ensure that all patients are assessed objectively to the same system and thereby placed in a priority order for preventative aids. It also provides evidence to manage the need to purchase equipment. The Waterlow assessment is another tool in the armoury of nurses, but it is not a replacement for their knowledge and their skills (Waterlow 2009). 5.5 A Waterlow assessment tool (see Appendix 1) must be used to assess the patient and the Waterlow score must be calculated and documented within the patient s hand held notes. However, it is acknowledged that the Waterlow score must be used in conjunction with clinical judgement and when the patient s condition changes and not in isolation. Patients who are identified as being at risk of developing pressure ulcers must have a multidisciplinary plan of care detailing interventions required, implemented and evaluated, in accordance with the National Institute of Health and Clinical Excellence clinical guidelines. The assessment of the patients risk, utilising the Waterlow score and practitioners clinical judgement must be undertaken no less than weekly throughout the episode of care and documented in the patient s multidisciplinary notes. Additional assessments documenting both the Waterlow score and the practitioner s clinical judgement must also be undertaken when changes in the patient s medical condition or environment occur. 5.6 A preventative care plan for all patients assessed as at risk of developing pressure ulcers must be implemented, this should involve the patient and relative/carers, and must include a repositioning schedule. The Skin, Surface, Keep moving, Incontinence, Nutrition (SSKIN) care bundle should be implemented to monitor for early signs of tissue damage and verbal and written information provided to patients, relatives and carers. SSKIN care bundle can be found here: http://www.shropscommunityhealth.nhs.uk/content/doclib/10790.pdf http://www.shropscommunityhealth.nhs.uk/content/doclib/10791.pdf 5.7 SSKIN Assessment: To maintain and improve tissue tolerance to pressure in order to prevent injury. Skin condition should be inspected and documented daily and any changes should be recorded as soon as they are observed. Inspection must be documented. Initial skin assessment should take into account the following bony prominences: - sacrum, heels, hips, ankles, elbows, occiput, to identify early stages of pressure damage. Identify the condition of skin, dryness, cracking, erythema, maceration, fragility, heat and induration. 5.7.1 Patient assessment: History and physical examination should be undertaken alongside the assessment of the patient s pressure ulcer. Patients overall physical and psycho-social health will affect the management and prevention of pressure ulcers. 5.7.2 Nutritional Assessment and Management: Ensure adequate dietary intake to prevent malnutrition to the extent that this is compatible with the individual s wishes or condition. It is important that a full nutritional assessment be carried out for any patients who are at risk of developing a pressure ulcer. The assessment must consider general nutritional appearance, clinical condition, patient s weight, height and percentage weight loss, usual and current dietary intake and any areas of concerns such as low levels of albumin, total protein or haemoglobin. If there are considerable nutritional concerns then discussions should be made with dieticians, GPs and the Tissue Viability Service. It has been cited that protein calorie malnutrition is a major factor in the development of pressure ulcers because it reduces the body s ability to heal and repair itself (King 2003). Many elderly people, especially those who live alone or those with disabilities, may be malnourished. They are often deficit of minerals and vitamins in addition to being protein deficit (King 2003). Guidelines for Prevention and Management 969-31643 6 April 2016

Nutritional supplements should be considered in order to improve their status and assist in the healing of pressure ulcers. A nationally recognised nutritional assessment tool is the MUST assessment tool and this will incorporate the body mass index assessment and is recommended by SCHT, (BAPEN 2003). Hydration assessment, dehydration should be avoided in order to maintain an adequate circulating blood volume and good skin and tissue perfusion. 5.8 Pain Assessment: Assess all patients for pain related to the pressure ulcer, for its treatment and document. Manage pain by eliminating or controlling the source of pain (e.g. covering wounds, adjusting support services, repositioning), provide medication or other methods of pain relief as needed and appropriate. Seek specialist advice if necessary, use appropriate wound assessment tool to document and evaluate patient s pain and treatments. 5.9 Moving and Handling Techniques: In all care settings individuals considered to be at risk of developing pressure ulcers should have a personalised written prevention plan which will include a pressure redistributing device. Benefit may be derived from a variety of pressure ulcer prevention devices. Please consult with the SCHT Community Equipment Service for further advice regarding pressure relieving equipment; Community Equipment Services, Unit D6, Hortonwood 7, Hortonwood, Telford, TF1 7GP. Tel; 01952 603838 email; community.equipmentservices@shropcom.nhs.uk 5.10 Skin injury due to friction and shear forces should be minimised through correct positioning, transferring and repositioning techniques. Skin must be protected against the adverse effects of external mechanical forces, pressure, friction and shear. Any individual who is assessed to be at risk of developing pressure ulcers should be repositioned if it is medically safe to do so. Frequency of repositioning should be consistent with overall goals. Documentation to record repositioning should be consistently completed, (see appendix 4). As the patient s condition improves, then the potential for improving mobility and activity status exist, rehabilitation efforts may be initiated, if consistent with the overall goals of therapy. Maintaining activity levels, mobility and range of movement is an appropriate goal for most individuals. All interventions and outcomes should be monitored and documented. Whenever possible avoid positioning patients directly on a pressure ulcer or directly on a bony prominence unless this is contra-indicated by their general treatment objectives, in which instance an adequate pressure relieving device (e.g. an alternating pressure device) should be implemented. Patients at risk of developing pressure ulcers because of the time spent sitting in a chair should be allocated a chair of the correct height in addition to a pressure relieving device (see appendices 5, 6 and 7). The period of time should be defined in the individual care plan but generally will not be more than two hours. Individuals, where appropriate, should be encouraged to reposition themselves if this is possible. Individuals at risk of pressure ulcers who are likely to spend substantial periods of time in a chair or wheelchair should generally be provided with a pressure redistributing device. Individuals who are able should be taught to redistribute weight every fifteen minutes. Periods spent immobile in chairs should be limited to 2 hours or less per session unless their clinical condition prevents doing so. 5.11 Transportation: Pressure ulcer prevention will include time spent in transit or time spent at appointments or during social activities. If a patient is at risk and has been advised to use a pressure reducing/relieving device then advice should be given to the patient about what to use during these times. Check if pressure reducing/relieving devices are available for patient appointments and/or seek advice from the SCHT Community Equipment Service. Patients must ensure that vehicle insurance companies are aware of any equipment being used during transportation, such as cushions. 5.12 Pressure ulcer assessment: Assess the pressure ulcer recording location, grade, size, wound bed, exudate, pain and status of surrounding skin. Care should be taken to identify undermining and sinus formation. All patients with wounds should have a Shropshire Guidelines for Prevention and Management 969-31643 7 April 2016

Wound Care Assessment, completed by all clinical staff (see appendix 2). All pressure ulcers should be reassessed daily if the condition of the patient or if the wound deteriorates and re-evaluation of the treatment plan should be initiated. 5.13 Ungradable pressure ulcers: this is where the actual depth of the ulcer is completely obscured by slough (yellow, tan, grey, green, brown, and black, Eschar) in the wound bed (see appendix 3). Until enough slough is removed to expose the base of the wound, the true depth cannot be determined; Suspected Deep Tissue Injury S/DTI should be reported in the usual way through Datix. TVS will then decide the grade following wound debridement (normally after 2 weeks) when the ulcer depth can be established and the pressure ulcer accurately graded. NB: Pressure ulcers should not be reverse graded. When healing they should be documented as healing and the original grade. 5.14 Wound Assessment and management: All pressure ulcers should be assessed utilizing Shropshire s wound care assessment form. The wounds should be assessed at each dressing change (see appendix 2). All pressure ulcers must be photographed in accordance with Shropshire s Wound Photography Guideline (2016) http://www.shropscommunityhealth.nhs.uk/content/doclib/10640.pdf and an evidence based management plan implemented utilising the guidance within Shropshire s wound care formulary (2016). www.telfordccg.nhs.uk/download.cfm?doc=docm93jijm4n9528. 5.15 Reporting of pressure ulceration: All pressure ulcers grade 2 and above must be datix reported using the appropriate datix reporting form. All grade 3 and 4 pressure ulcers should be reported as a serious incident as per trust policy and procedure. All grade 3 and 4 pressure ulcers developed in an independent care home setting must be reported to the Care Quality Commission. Any pressure ulcer deterioration must also be reported via DATIX. 5.16 Action against Advice: Where healthcare professionals are unable to implement a plan of care due to service user non-concordance for whatever reason, this must be clearly documented. All attempts to mitigate potential risk, alternative/reduced strategies, encouragement, supervision, assistance, reassurance, support, education and on-going assessment must be documented. Non-concordance must be escalated to ward manager/matron/team leader. 6 Consultation In the development of this guidance the following have been included in the consultation process: Stephen Gregory, Director Nursing and Quality; Catherine Ball, Tissue Viability Nurse; George English, Clinical Lead for Community Nursing; Claire Wheeler, Community Practice Teacher. Infection Prevention and Control Team Carol Bayley, Community Equipment Service Manager Guidelines for Prevention and Management 969-31643 8 April 2016

7 Dissemination and Implementation: These guidelines will be disseminated to all relevant clinical teams by: a) Managers Informed via DATIX system who then confirm they have disseminated to staff as appropriate b) Staff via Team Brief c) Via Tissue Viability Link Nurses d) Published to the staff zone of the trust website e) Training and raising awareness will be included as part of the Wound Assessment and Management Study Seminars delivered by the Tissue Viability Service. 8 Monitoring Compliance Tissue Viability Clinical Lead and team leaders will monitor compliance of these guidelines by: a) Clinical audits, including clinical record keeping audit and wound care audit. b) Responding to any incidences reported on the Trust incident reporting system and ensuring appropriate lessons learnt are identified and action plans implemented and completed. c) Monitor feedback from clinical staff and that any concerns raised are addressed. d) The Tissue Viability Service will provide a range of training and educational opportunities for all health care professionals. All clinical healthcare staff must attend mandatory training on pressure ulcer prevention and management every 3 years, as changes are occurring within this speciality as a result of on-going research. This mandatory training will underpin the implementation of the policy. 9 References European Advisory Panel (2014) Treatment Guidelines http://www.epuap.org/wp-content/uploads/2010/10/quick-reference-guide-digital- NPUAP-EPUAP-PPPIA-16Oct2014.pdf National Institute for Clinical Excellence (2014) The Prevention and treatment of Pressure Ulcers, London, NICE. grading chart NHS Midlands and East 2012 adapted from EPUAP/NPUAP (2009) European Advisory Panel (2009) Treatment Guidelines http://www.epuap.org/guidelines/final_quick_treatment.pdf Shropshire Tissue Viability Group (2016) Wound Management Formulary. Waterlow J (2009) Prevention http://www.judy-waterlow.co.uk/index.htm King C L, Elia M, Stroud M A, Stratton R J. The Predicted Validity of The Malnutrition Universal Screening Tool (MUST) With Regard to Mortality and Length of Stay in Elderly Patients. Clinical Nutrition (2003) No 22 The British Association or Parenteral and Enteral Nutrition (2003) The MUST Explanatory Booklet BAPEN (2003) Guidelines for Prevention and Management 969-31643 9 April 2016

10 Associated Documents The following Trust policies should be read in conjunction with these guidelines: 11 Appendices Consent to Examination or Treatment Policy Confidentiality Code of Practice Information Security Policy Incident Reporting Policy Data Protection Policy Records Management Policy Clinical Record Keeping Policy Pan West Midlands Policy and procedure for safeguarding adults NHS Number Retrieval, Verification and Use Procedure SSKIN Booklet (Surface, Skin, Keep Moving, Incontinence, Nutrition) http://www.shropscommunityhealth.nhs.uk/content/doclib/10790.pdf and http://www.shropscommunityhealth.nhs.uk/content/doclib/10791.pdf These policies can be found in the Policy section of the Trust s website: http://www.shropscommunityhealth.nhs.uk/rte.asp?id=10667 Appendix 1 Appendix 2 Appendix 3 Appendix 4 Appendix 5 Appendix 6 Appendix 7 Appendix 8 Waterlow risk assessment tool Wound assessment chart The EPUAP Guide to Grading Repositioning Chart Flow chart to assist in the appropriate prescription of pressure reducing/relieving cushions for armchairs Flow chart to assist in the appropriate prescription of dynamic pressure relieving mattresses Flow chart to assist in the appropriate prescription of static pressure reducing mattresses Specialist Equipment Order Form Guidelines for Prevention and Management 969-31643 10 April 2016

Appendix 1 Waterlow Risk Assessment Tool Guidelines for Prevention and Management 969-31643 11 April 2016

Appendix 2 Wound Assessment Chart Affix patient label if available Name: DOB: Address: NHS No: Factors which could delay healing: (Please tick relevant box) Immobility Pain Assessment completed? Diabetes Poor Nutrition Respiratory/Circulatory Incontinence Disease Body Diagram Wound Infection Oedema Waterlow Anaemia Medication Warfarin Steroids Chemotherapy Other Allergies & Sensitivities Feet Diagram Mark location with x and number each wound Type of Wound (tick all relevant boxes) Pressure ulcer Leg ulcer Surgical wound Diabetic ulcer Other, specify Total number and duration of each type of wound..................... Referred to: (tick all relevant boxes) TVN Dietician Podiatrist Physiotherapist Datix report. SI report Other (please specify).. Equipment required: Specialist Mattress Cushion Heel Protector Other (please specify)..... Guidelines for Prevention and Management 969-31643 12 April 2016

Appendix 3 The EPUAP Guide to Grading Grade 1: non-blanchable erythema of intact skin. Discolouration of the skin, warmth, oedema, induration or hardness may also be used as indicators, particularly on individuals with darker skin. Grade 2: partial thickness skin loss involving epidermis, dermis, or both. The ulcer is superficial and presents clinically as an abrasion or blister. Grade 3: full thickness skin loss involving damage to or necrosis of subcutaneous tissue that may extend down to, but not through underlying fascia. Guidelines for Prevention and Management 969-31643 13 April 2016

Ungradeable : Full thickness tissue loss in which the actual depth is completely obscured by slough/eschar (yellow, tan, grey, green, brown, black, eschar) in the wound bed. Until enough slough/eschar is removed to expose the base of the wound bed, the true depth cannot be determined. Grade 4: extensive destruction, tissue necrosis, or damage to muscle, bone, or supporting structures with or without full thickness skin loss. Line diagrams reproduced by kind permission of Huntleigh Healthcare Ltd European Advisory Panel Guidelines for Prevention and Management 969-31643 14 April 2016

Appendix 4 Repositioning Chart Repositioning Schedule Patients Name NHS No DOB Date Time Left side Back Right side Comments Other position Signature Appendix 5 Flow chart to assist in the appropriate prescription of pressure reducing/relieving cushions for armchairs Flow chart to assist in the appropriate prescription of pressure reducing/relieving cushions for armchairs Very high risk patient Up to and including Grade 3/4 Aura cushion or alternative weight limit 120kg/19 stone via S.E.O form No High risk patient No With no or those with a Grade 1 2 Repose weight limit 23 stone via E.O form or Harvest gel for more stable surface weight limit 110kg/17stone via S.E.O form Medium risk patient Low risk patient With no Flow chart for guidance only, the individual assessor needs to consider all other factors i.e. length of stay in bed, diagnosis, diet etc. Propad weight limit 108 kg/17 stone via E.O form or no action reassess if change in condition Guidelines for Prevention and Management 969-31643 15 April 2016

Appendix 6 Flow chart to assist in the appropriate prescription of dynamic pressure relieving mattresses Flow chart to assist in the appropriate prescription of dynamic pressure relieving mattresses via S.E.O form Very high risk patient With a Grade 3 4 on heel &/or other area Nimbus 3 weight limit 250kg/39stone or Quarto Prime but no sore heel Very high risk patient With a Grade 3 4 Nimbus 2 weight limit 250kg/39 stone No High risk patient With a Grade 2-3 Autoexcel weight limit 203kg/32 stone or Tally Quattro weight limit 60kg/25 stone min 26kg/4stone or Soft Form Premier Active if a stable surface is needed No Medium risk patient With a Grade 1 2 Flow chart for guidance only, the individual assessor needs to consider all other factors i.e. length of stay in bed, diagnosis, diet etc. Alpha xcell weight limit 140kg/22 stone or High Spec Static Mattress (see flow chart for static systems) Appendix 7 Flow chart to assist in the appropriate prescription of static pressure reducing mattresses Flow chart to assist in the appropriate prescription of static pressure reducing mattresses. Very high risk patient With a Grade 3 4 Please refer to dynamic systems flow chart. No High risk patient With a Grade 1 2 Repose overlay via E.O form or consider dynamic systems Memory foam if more stable surface needed via S.E.O form No With a Grade 1 2 heel Consider MSS heel pad via S.E.O form or Repose heel protector via E.O form Medium risk patient Low risk patient With no Flow chart for guidance only, the individual assessor needs to consider all other factors i.e. length of stay in bed, diagnosis, diet etc. Soft form mattress or Propad Waterlow 19 weight limit 165 kg/26 stone or no action required reassess if change in condition Guidelines for Prevention and Management 969-31643 16 April 2016

Appendix 8 Specialist Equipment Order Form 12 13 Specialist Equipment Order Form Please return form to: Community Equipment Services, Unit D6, Hortonwood 7, Hortonwood, Telford TF1 7GP. Telephone: 01952 603838 Fax: 01952 603782 email: Community.EquipmentServices@shropcom.nhs.uk Please complete all sections of this form giving as much detail as possible. Inadequately completed forms will be returned for completion, which will obviously delay the provision of the appropriate equipment. Patient Details: Name: Address: Post Code: Date of Birth: NHS Number: Telephone No: Alternative contact name number and relationship: Does the service user live alone?: Any hazards if known: G.P. Details: Name: NHS Code: Address: Telephone No: Assessing professional details: Name: Agency: Address: Telephone No: Date of Assessment: Signature: Guidelines for Prevention and Management 969-31643 17 April 2016

Describe current health status: Diagnosis and prognosis: Height: Weight: Circumference of abdomen/girth: Mobility (please describe if they have the ability to achieve a change of position when lying or sitting. How they transfer,walk and move from lying to sitting) Present Skin Condition: Current Waterlow Score: Sore Grade: Sore Site: History of pressure sores: Site: Grade: No of Hours on Bedrest: No of Hours Sitting/Mobile: Number of handling transfers daily: 14 Clinical reasoning for equipment requested: (Please include any consideration given to informal/formal carers) Guidelines for Prevention and Management 969-31643 18 April 2016

What Type of equipment is required: Bed: Type: Cotsides: Type: Bumpers: Type: Mattress system: Type: Cushion: Type: (If cushion is required for a wheelchair, please request from Wheelchair Services) Stand aid: Type: Hoist Type: Sling: Type: Other: Supplier Info (if new please provide supporting literature):.. Accommodation (Current): Please describe access to property, where the equipment is to be sited and on which level. NB All beds are sited downstairs wherever possible, if not, an access visit is required to assess the environment and accessibility upstairs. Please ensure that there is sufficient space at the property to install bed appropriately. Arrangements made to install equipment and name of person who will demonstrate equipment: NB If care agency is involved, the demonstration must also include the care manager. Discharge Date: Care Package commencement date and name and contact number of agency: Additional comments: Guidelines for Prevention and Management 969-31643 19 April 2016